We thus first integrated the data from the Chinese DLBCL cohort, which includes WGS and WES data from 96 pairs of tumour/control samples and targeted sequencing data from 204 tumour‐only samples, to identify somatically occurring (tumour‐specific) mutations in CD70. Here, CD70 is linked to diffuse large B-cell lymphoma.